Revance Therapeutics, Inc. (RVNC)

Last Closing Price: 3.02 (2024-05-17)

Loss Ratio (Quarterly)

Loss Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The loss ratio is calculated by taking the incurred underwriting losses and then dividing them by earned premium. Calculated as: Underwriting Losses Total / Net Premiums Earned

Revance Therapeutics, Inc. (RVNC) Loss Ratio data is not available.

Figures for fiscal quarter ending 2024-03-31
Income Statement Financials
$51.94M
$-53.15M
$14.91M
$37.02M
$98.76M
$-46.83M
$-2.70M
$-49.52M
$-49.52M
$-49.52M
$-49.52M
$-53.15M
$-49.52M
$-46.83M
$-45.45M
91.92M
91.92M
$-0.58
$-0.58
Balance Sheet Financials
$369.69M
$17.50M
$138.43M
$508.12M
$68.90M
$424.84M
$537.89M
$606.79M
$-98.67M
$-107.40M
$-98.67M
104.41M
Cash Flow Statement Financials
$-65.94M
$-31.71M
$92.83M
$144.75M
$139.93M
$-4.82M
$8.99M
--
--
Fundamental Metrics & Ratios
5.37
--
--
1.30
-4.36
71.29%
-90.16%
-90.16%
--
-95.36%
-102.34%
$-67.65M
Loss Ratio
--
--
--
0.10
0.30
1.74
51.79
50.19%
46.11%
-9.75%
-15.18%
$-0.95
$-0.74
$-0.72